CCL2 and atherosclerosis: The expression patterns of the major migration-driving chemokines MCP-1 (CCL2), MIP-1α (CCL3), MIP-1β (CCL4), RANTES (CCL5), and fractalkine (CX3CL1) in patients with atherosclerosis were of particular interest in this study.